Paolo Ditonno

884 total citations
15 papers, 470 citations indexed

About

Paolo Ditonno is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Paolo Ditonno has authored 15 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 8 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Paolo Ditonno's work include Multiple Myeloma Research and Treatments (11 papers), Ubiquitin and proteasome pathways (4 papers) and Protein Degradation and Inhibitors (3 papers). Paolo Ditonno is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), Ubiquitin and proteasome pathways (4 papers) and Protein Degradation and Inhibitors (3 papers). Paolo Ditonno collaborates with scholars based in Italy, Canada and United Kingdom. Paolo Ditonno's co-authors include Angelo Vacca, Roberto Ria, Vito Racanelli, Maria Antonia Frassanito, Franco Dammacco, Patrizia Leone, Doménico Ribatti, Simona Berardi, Antonio Giovanni Solimando and Sebastiano Cicco and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Oncogene.

In The Last Decade

Paolo Ditonno

15 papers receiving 465 citations

Peers

Countries citing papers authored by Paolo Ditonno

Since Specialization

Citations

This map shows the geographic impact of Paolo Ditonno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Ditonno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Ditonno more than expected).

Fields of papers citing papers by Paolo Ditonno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Ditonno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Ditonno. The network helps show where Paolo Ditonno may publish in the future.

Co-authorship network of co-authors of Paolo Ditonno

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Ditonno. A scholar is included among the top collaborators of Paolo Ditonno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Ditonno. Paolo Ditonno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 2024 ·Biomarker Research ·Patrizia Leone, Eleonora Malerba, Marcella Prete, Antonio Giovanni Solimando, Giorgio Alberto Croci, Paolo Ditonno, Marco Tucci, Nicola Susca, Afshin Derakhshani, Antoine Dufour, Vallì De Re, Nicola Silvestris, Vito Racanelli	3
2	Unraveling the Role of Peroxisome Proliferator-Activated Receptor β/Δ (PPAR β/Δ) in Angiogenesis Associated with Multiple Myeloma 2023 ·Cells ·Patrizia Leone, Antonio Giovanni Solimando, Marcella Prete, Eleonora Malerba, Nicola Susca, Afshin Derakhshani, Paolo Ditonno, Carolina Terragna, Michèle Cavo, Nicola Silvestris, Vito Racanelli	4
3	Body Composition Change, Unhealthy Lifestyles and Steroid Treatment as Predictor of Metabolic Risk in Non-Hodgkin’s Lymphoma Survivors 2021 ·Journal of Personalized Medicine ·Antonella Daniele, Attilio Guarini, Simona De Summa, Miriam Dellino, (unknown), Sabino Ciavarella, Paolo Ditonno, Angelo Paradiso, Rosa Divella, (unknown), Eufemia Savino, (unknown), Carla Minoia	6
4	Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 2020 ·Journal of Clinical Medicine ·Giuseppe Di Lernia, Patrizia Leone, Antonio Giovanni Solimando, Alessio Buonavoglia, Ilaria Saltarella, Roberto Ria, Paolo Ditonno, Nicola Silvestris, Lucilla Crudele, Angelo Vacca, Vito Racanelli	50
5	Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 2018 ·Oncotarget ·Aurelia Lamanuzzi, Ilaria Saltarella, Vanessa Desantis, Maria Antonia Frassanito, Patrizia Leone, Vito Racanelli, Beatrice Nico, Doménico Ribatti, Paolo Ditonno, Marcella Prete, Antonio Giovanni Solimando, (unknown), Angelo Vacca, Roberto Ria	46
6	Bone marrow endothelial cells sustain a tumor-specific CD8⁺ T cell subset with suppressive function in myeloma patients 2018 ·OncoImmunology ·Patrizia Leone, Giuseppe Di Lernia, Antonio Giovanni Solimando, Sebastiano Cicco, Ilaria Saltarella, Aurelia Lamanuzzi, Roberto Ria, Maria Antonia Frassanito, Maurilio Ponzoni, Paolo Ditonno, Franco Dammacco, Vito Racanelli, Angelo Vacca	53
7	Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing 2015 ·Blood ·Patrizia Leone, Simona Berardi, Maria Antonia Frassanito, Roberto Ria, Vallì De Re, Sebastiano Cicco, Stefano Battaglia, Paolo Ditonno, Franco Dammacco, Angelo Vacca, Vito Racanelli	82
8	A HGF/cMET Autocrine Loop Is Operative in Multiple Myeloma Bone Marrow Endothelial Cells and May Represent a Novel Therapeutic Target 2014 ·Clinical Cancer Research ·(unknown), Michele Moschetta, Maria Antonia Frassanito, Simona Berardi, Ivana Catacchio, Roberto Ria, Vito Racanelli, Antonella Caivano, Antonio Giovanni Solimando, Daniele Vergara, Michele Maffia, Dominga Latorre, Antonia Rizzello, Alfredo Zito, Paolo Ditonno, Eugenio Maiorano, Doménico Ribatti, Angelo Vacca	53
9	HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target 2013 ·Clinical Cancer Research ·Roberto Ria, Ivana Catacchio, Simona Berardi, Annunziata De Luisi, Antonella Caivano, Cláudia Piccoli, Vitalba Ruggieri, Maria Antonia Frassanito, Doménico Ribatti, Beatrice Nico, Tiziana Annese, Simona Ruggieri, Attilio Guarini, Carla Minoia, Paolo Ditonno, Emanuele Angelucci, Daniele Derudas, Michele Moschetta, Franco Dammacco, Angelo Vacca	50
10	Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross‐talk in the bone marrow of multiple myeloma patients 2012 ·The Journal of Pathology ·(unknown), Michele Moschetta, Paolo Ditonno, Roberto Ria, (unknown), Annunziata De Luisi, Simona Berardi, Maria Antonia Frassanito, Emanuele Angelucci, Daniele Derudas, Giorgina Specchia, Paola Curci, Vincenzo Pavone, (unknown), Doménico Ribatti, Barbara Bottazzi, Alberto Mantovani, Marco Presta, Franco Dammacco, Angelo Vacca	31
11	Could Multiple Myeloma VEGF Modify the Systemic Microcirculation? 2011 ·Advances in experimental medicine and biology ·Sebastiano Cicco, Paolo Ditonno, Antonia Reale, (unknown), (unknown), Ivana Catacchio, Roberto Ria, Angelo Vacca	3
12	Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets 2011 ·Oncogene ·Simona Berardi, Antonella Caivano, Roberto Ria, Beatrice Nico, Rocco Savino, Rosa Terracciano, Giacoma De Tullio, (unknown), Annunziata De Luisi, Michele Moschetta, Giuseppe Mangialardi, Ivana Catacchio, Antonio Basile, Attilio Guarini, Alfredo Zito, Paolo Ditonno, Pellegrino Musto, Franco Dammacco, Doménico Ribatti, Angelo Vacca	28
13	Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma 2009 ·European Journal of Cancer ·Michele Moschetta, Giulia Di Pietro, Roberto Ria, Antonio Gnoni, Giuseppe Mangialardi, Attilio Guarini, Paolo Ditonno, Pellegrino Musto, Fiorella D’Auria, Maria Rosaria Ricciardi, Franco Dammacco, Doménico Ribatti, Angelo Vacca	51
14	CEOP-B alternated with VIMB in intermediate-grade and high-grade non-Hodgkin's lymphoma: a pilot study. 1995 ·Journal of Clinical Oncology ·M. De Lena, Paolo Ditonno, Vito Lorusso, Mario Brandi, (unknown), F Marzullo, (unknown), (unknown)	3
15	ORAL VERSUS INTRAVENOUS CMF IN METASTATIC BREAST-CANCER - A RANDOMIZED STUDY 1994 ·International Journal of Oncology ·(unknown), (unknown), Paolo Ditonno, Annamaria Catino, Vito Lorusso, (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact